Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine

被引:7
作者
Milazzo, L [1 ]
Rusconi, S
Testa, L
La Seta-Catamancio, S
Galazzi, M
Kurtagic, S
Citterio, P
Gianotto, M
Grassini, A
Adorni, F
d'Arminio-Monforte, A
Galli, M
Moroni, M
机构
[1] Univ Milan, Osped Luigi Sacco, Ist Malattie Infett & Trop, Milan, Italy
[2] CNR, Ist Tecnol Biomed Avanzate, I-20131 Milan, Italy
来源
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 1999年 / 22卷 / 01期
关键词
D O I
10.1097/00042560-199909010-00013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:101 / 103
页数:3
相关论文
共 15 条
  • [1] Aber V, 1996, LANCET, V348, P283, DOI 10.1016/S0140-6736(96)05387-1
  • [2] Baxter J, 1999, ANTIVIR THER S, V4, P43
  • [3] Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease
    Cameron, DW
    Heath-Chiozzi, M
    Danner, S
    Cohen, C
    Kravcik, S
    Maurath, C
    Sun, E
    Henry, D
    Rode, R
    Potthoff, A
    Leonard, J
    [J]. LANCET, 1998, 351 (9102) : 543 - 549
  • [4] Antiretroviral therapy for HIV infection in 1996 - Recommendations of an international panel
    Carpenter, CCJ
    Fischl, MA
    Hammer, SM
    Hirsch, MS
    Jacobsen, DM
    Katzenstein, DA
    Montaner, JSG
    Richman, DD
    Saag, MS
    Schooley, RT
    Thompson, MA
    Vella, S
    Yeni, PG
    Volberding, PA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (02): : 146 - 154
  • [5] Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine
    Collier, AC
    Coombs, RW
    Schoenfeld, DA
    Bassett, RL
    Timpone, J
    Baruch, A
    Jones, M
    Facey, K
    Whitacre, C
    McAuliffe, VJ
    Friedman, HM
    Merigan, TC
    Reichman, RC
    Hooper, C
    Corey, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (16) : 1011 - 1017
  • [6] Cooper DA, 1997, LANCET, V349, P1413, DOI 10.1016/S0140-6736(97)04441-3
  • [7] Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial
    Durant, J
    Clevenbergh, P
    Halfon, P
    Delgiudice, P
    Porsin, S
    Simonet, P
    Montagne, N
    Boucher, CAB
    Schapiro, JM
    Dellamonica, P
    [J]. LANCET, 1999, 353 (9171) : 2195 - 2199
  • [8] Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection - 100-week follow-up
    Gulick, RM
    Mellors, JW
    Havlir, D
    Eron, JJ
    Gonzalez, C
    McMahon, D
    Jonas, L
    Meibohm, A
    Holder, D
    Schleif, WA
    Condra, JH
    Emini, EA
    Isaacs, R
    Chodakewitz, JA
    Richman, DD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (01): : 35 - 41
  • [9] A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter
    Hammer, SM
    Katzenstein, DA
    Hughes, MD
    Gundacker, H
    Schooley, RT
    Haubrich, RH
    Henry, WK
    Lederman, MM
    Phair, JP
    Niu, M
    Hirsch, MS
    Merigan, TC
    Blaschke, TF
    Simpson, D
    McLaren, C
    Rooney, J
    Salgo, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (15) : 1081 - 1090
  • [10] Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy
    Iversen, AKN
    Shafer, RW
    Wehrly, K
    Winters, MA
    Mullins, JI
    Chesebro, B
    Merigan, TC
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (02) : 1086 - 1090